Inflammatory breast cancer and development of brain metastases: risk factors and outcomes

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2015-04-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10549-015-3381-8PMID 25893587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain metastases in breast cancer.

  2014cited by this paper
• Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States.

  2013cited by this paper
• Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States

  2013cited by this paper
• Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype

  2012cited by this paper
• A meta‐analysis evaluating stereotactic radiosurgery, whole‐brain radiotherapy, or both for patients presenting with a limited number of brain metastases

  2012cited by this paper
• Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Central Nervous System Metastases

  2011cited by this paper
• International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.

  2011cited by this paper
• Incidence of and survival following brain metastases among women with inflammatory breast cancer.

  2010cited by this paper
• The effect of early detection of occult brain metastases in HER2-positive breast cancer patients on survival and cause of death.

  2010cited by this paper
• Metastatic behavior of breast cancer subtypes.

  2010cited by this paper
• Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

  2009cited by this paper
• Validation of the graded prognostic assessment index for patients with brain metastases

  2009cited by this paper
• Metastasis: from dissemination to organ-specific colonization

  2009cited by this paper
• Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases.

  2009cited by this paper
• A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.

  2008cited by this paper
• Brain metastases in breast cancer: prognostic factors and management

  2008influential reference
• Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood–brain barrier

  2007cited by this paper
• Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis

  2007cited by this paper
• Inflammatory breast cancer (IBC) and patterns of recurrence

  2007cited by this paper
• Competing risk analysis using R: an easy guide for clinicians

  2007cited by this paper
• Central nervous system metastases in patients with high‐risk breast carcinoma after multimodality treatment

  2004influential reference
• NCCN breast cancer clinical practice guidelines in oncology: an update.

  2003cited by this paper
• Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?

  2003cited by this paper
• Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival.

  2003cited by this paper
• Non‐parametric confidence interval estimation for competing risks analysis: application to contraceptive data

  2002cited by this paper
• Brain metastases in breast cancer: prognostic factors and management.

  1999cited by this paper
• Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

  1998cited by this paper
• Inflammatory breast carcinoma incidence and survival

  1998cited by this paper
• Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.

  1997cited by this paper
• Brain metastases in breast cancer; natural history, prognostic factors and outcome

  1993cited by this paper
• A randomized trial of surgery in the treatment of single metastases to the brain.

  1990cited by this paper
• A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

  1988cited by this paper
• Breast Cancer: Metastatic Patterns and Their Prognosis

  1988cited by this paper
• Breast carcinoma: Pattern of metastasis at autopsy

  1983cited by this paper
• Central nervous system metastasis from breast carcinoma autopsy study

  1983cited by this paper
• Intracerebral metastases in solid‐tumor patients: Natural history and results of treatment

  1981cited by this paper
• The natural history of breast cancer patients with brain metastases

  1979cited by this paper
• The management of metastases to the brain by irradiation and corticosteroids.

  1971cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Comparison Bioinformatic Analysis of Extracellular Vesicles-Related Genes and MicroRNAs in Breast Cancer

  2025cites this paper
• Pharmacological inhibition of NMDA receptors reduces migration and viability in triple-negative inflammatory breast cancer cell lines

  2025cites this paper
• Soluble E-cadherin Drives Brain Metastasis in Inflammatory Breast Cancer

  2025cites this paper
• Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities

  2024cites this paper
• Identification of key genes in HER2-positive breast cancer with brain metastasis via bioinformatics methods

  2023cites this paper
• Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer

  2022cites this paper
• Systemic Therapy for HER2-Positive Metastatic Breast Cancer: Moving Into a New Era.

  2022cites this paper
• NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis.

  2021cites this paper
• Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer

  2021cites this paper
• Prolonged Survival in Patients with Metastatic HER2-Positive Inflammatory Breast Cancer: A Case Report and Review of the Literature

  2021cites this paper
• Management of brain metastases according to molecular subtypes

  2020cites this paper
• Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?

  2020cites this paper
• Risk Factors for Brain Metastases in Patients with Renal Cell Carcinoma

  2020cites this paper
• Management of Brain and Leptomeningeal Metastases from Breast Cancer

  2020cites this paper
• Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas

  2019cites this paper
• Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer

  2019cites this paper
• Patterns of recurrence and metastasis in BRCA1/BRCA2‐associated breast cancers

  2019cites this paper
• Inflammatory Breast Cancer: a Separate Entity

  2019cites this paper
• The Current and Evolving Role of Radiation Therapy for Central Nervous System Metastases from Breast Cancer

  2019cites this paper
• Development of CNS metastases and survival in patients with inflammatory breast cancer

  2018cites this paper
• Analysis of Hierarchical Organization in Gene Expression Networks Reveals Underlying Principles of Collective Tumor Cell Dissemination and Metastatic Aggressiveness of Inflammatory Breast Cancer

  2017cites this paper
• Inflammatory breast cancer: a model for investigating cluster-based dissemination

  2017cites this paper
• Brain metastases in malignant pleural mesothelioma

  2016cites this paper
• Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer

  2015cites this paper